Literature DB >> 6356933

Epinephrine sensitivity with respect to metabolic rate and other variables in women.

L Sjöström, Y Schutz, F Gudinchet, L Hegnell, P G Pittet, E Jéquier.   

Abstract

A test for determination of epinephrine sensitivity has been worked out using six healthy young women. Variables considered were metabolic rate, heart rate, respiratory frequency, blood pressure, blood glucose, plasma insulin, glycerol, free fatty acids, and lactate. After established basal conditions, epinephrine was infused at rates of 0.01, 0.03, and 0.1 microgram X kg fat-free mass-1 X min-1. Most variables responded to epinephrine in a dose-dependent manner. Physiological threshold plasma concentrations of epinephrine ranged from 95 to 250 pg/ml for different variables. Calculated maximal responses ranged from approximately -15% to +900% of basal values and infusion rates giving half-maximal responses from approximately 15 to 190 ng X kg fat-free mass-1 X min-1. On an average, metabolic rate increased by 8, 16, and 29%, respectively, at the three infusion rates, and the maximal metabolic response was calculated to be approximately 35%. The error in determining epinephrine-induced increments in metabolic rate was 7% of the response. As calculated from nonprotein RQ, carbohydrate oxidation increased and lipid oxidation decreased rapidly during the first 10 min of epinephrine infusion. Later, fat oxidation became more important. Results on epinephrine plasma metabolic clearance rate agreed with earlier results in the literature.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6356933     DOI: 10.1152/ajpendo.1983.245.5.E431

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  14 in total

1.  Oxygen uptake as related to work rate increment during cycle ergometer exercise.

Authors:  J E Hansen; R Casaburi; D M Cooper; K Wasserman
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1988

2.  The metabolic and ventilatory response to the infusion of stress hormones.

Authors:  C Weissman; J Askanazi; R A Forse; A I Hyman; J Milic-Emili; J M Kinney
Journal:  Ann Surg       Date:  1986-04       Impact factor: 12.969

3.  Influences of variation in total energy intake and dietary composition on regulation of fat cell lipolysis in ideal-weight subjects.

Authors:  H Kather; E Wieland; A Scheurer; G Vogel; U Wildenberg; C Joost
Journal:  J Clin Invest       Date:  1987-08       Impact factor: 14.808

4.  Metabolic heat production and cardiovascular responses to an incremental intravenous infusion of adrenaline in healthy subjects.

Authors:  D G Maggs; I W Gallen; K Fone; I A Macdonald
Journal:  Clin Auton Res       Date:  1994-06       Impact factor: 4.435

Review 5.  Oxygen uptake kinetics during exercise.

Authors:  F Xu; E C Rhodes
Journal:  Sports Med       Date:  1999-05       Impact factor: 11.136

6.  Ephedrine activates brown adipose tissue in lean but not obese humans.

Authors:  A L Carey; M F Formosa; B Van Every; D Bertovic; N Eikelis; G W Lambert; V Kalff; S J Duffy; M H Cherk; B A Kingwell
Journal:  Diabetologia       Date:  2012-10-13       Impact factor: 10.122

7.  Haemodynamic changes and oxygen uptake during crossclamping of the thoracic aorta in dexmedetomidine pretreated dogs.

Authors:  S Gregoretti; T Henderson; D A Parks; S Gelman
Journal:  Can J Anaesth       Date:  1992-09       Impact factor: 5.063

8.  Thermogenic effect of adrenaline: interaction with insulin.

Authors:  O Selberg; S Schlaak; H J Balks; A von zur Mühlen; M J Müller
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1991

9.  Are the effects of noradrenaline, adrenaline and dopamine infusions on VO2 and metabolism transient?

Authors:  H Ensinger; T Weichel; K H Lindner; A Grünert; M Georgieff
Journal:  Intensive Care Med       Date:  1995-01       Impact factor: 17.440

10.  Systemic β-adrenergic stimulation of thermogenesis is not accompanied by brown adipose tissue activity in humans.

Authors:  Maarten J Vosselman; Anouk A J J van der Lans; Boudewijn Brans; Roel Wierts; Marleen A van Baak; Patrick Schrauwen; Wouter D van Marken Lichtenbelt
Journal:  Diabetes       Date:  2012-08-07       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.